{"DataElement":{"publicId":"5985734","version":"1","preferredName":"Breast Cancer AJCC Edition 8 Pathologic Tumor T Category","preferredDefinition":"Extent of the primary breast carcinoma based on clinical stage information combined with operative findings, and evidence obtained from pathology review when surgery is the first definitive therapy, using AJCC Ed. 8 criteria.","longName":"BRST_AJC8_PTH_T_CAT","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"2189063","version":"1","preferredName":"Breast Tumor Pathologic T Stage","preferredDefinition":"Information related to pathologic T stage of a breast tumor.","longName":"BRST_TUMOR_P_T","context":"NCI Standards","contextVersion":"1","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207099","version":"1","preferredName":"Pathologic T Stage","preferredDefinition":"Pathologic; caused by or altered by or manifesting disease or pathology.:One criteria of the TMN staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","longName":"C25610:C25728","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-1838-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5DFF578-1762-4DFB-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-07","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-07","modifiedBy":"TAYLORT","dateModified":"2017-11-17","changeDescription":"11/17/17 tt associated with CS/CSI. 9/13/17 tt transferred context; changed def - 1st letter upper case; changed Reg Status to Qualified.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6005564","version":"1","preferredName":"Breast Carcinoma American Joint Committee on Cancer Edition 8 T Category","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system.  T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion)._A grouping of items based on some commonality or by user defined characteristics.","longName":"6005564v1.0","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"13","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"T4","valueDescription":"Breast Cancer pT4 TNM Finding v8","ValueMeaning":{"publicId":"6005580","version":"1","preferredName":"Breast Cancer pT4 TNM Finding v8","longName":"6005580","preferredDefinition":"Breast cancer with tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT4 TNM Finding v8","conceptCode":"C139423","definition":"Breast cancer with tumor of any size with direct extension to the chest wall and/or to the skin (ulceration or macroscopic nodules); invasion of the dermis alone does not qualify as T4. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-91B6-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-91CF-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T4b","valueDescription":"Breast Cancer pT4b TNM Finding v8","ValueMeaning":{"publicId":"6005576","version":"1","preferredName":"Breast Cancer pT4b TNM Finding v8","longName":"6005576","preferredDefinition":"Breast cancer with ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d'orange) of the skin that does not meet the criteria for inflammatory carcinoma. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT4b TNM Finding v8","conceptCode":"C139425","definition":"Breast cancer with ulceration and/or ipsilateral macroscopic satellite nodules and/or edema (including peau d'orange) of the skin that does not meet the criteria for inflammatory carcinoma. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-916A-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-9183-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T4a","valueDescription":"Breast Cancer pT4a TNM Finding v8","ValueMeaning":{"publicId":"6005578","version":"1","preferredName":"Breast Cancer pT4a TNM Finding v8","longName":"6005578","preferredDefinition":"Breast cancer with extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT4a TNM Finding v8","conceptCode":"C139424","definition":"Breast cancer with extension to the chest wall; invasion or adherence to pectoralis muscle in the absence of invasion of chest wall structures does not qualify as T4. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-9190-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-91A9-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T3","valueDescription":"Breast Cancer pT3 TNM Finding v8","ValueMeaning":{"publicId":"6005582","version":"1","preferredName":"Breast Cancer pT3 TNM Finding v8","longName":"6005582","preferredDefinition":"Breast cancer with tumor size more than 50 mm in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT3 TNM Finding v8","conceptCode":"C139422","definition":"Breast cancer with tumor size more than 50 mm in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-91DC-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-91F5-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T2","valueDescription":"Breast Cancer pT2 TNM Finding v8","ValueMeaning":{"publicId":"6005584","version":"1","preferredName":"Breast Cancer pT2 TNM Finding v8","longName":"6005584","preferredDefinition":"Breast cancer with tumor size more than 20 mm, but not more than 50 mm in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT2 TNM Finding v8","conceptCode":"C139421","definition":"Breast cancer with tumor size more than 20 mm, but not more than 50 mm in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-9202-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-921B-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T1mi","valueDescription":"Breast Cancer pT1mi TNM Finding v8","ValueMeaning":{"publicId":"6005586","version":"1","preferredName":"Breast Cancer pT1mi TNM Finding v8","longName":"6005586","preferredDefinition":"Breast cancer with tumor size 1 mm or less in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT1mi TNM Finding v8","conceptCode":"C139417","definition":"Breast cancer with tumor size 1 mm or less in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-9228-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE72A02-9241-583F-E053-F662850A0711","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T1a","valueDescription":"Breast Cancer pT1a TNM Finding v8","ValueMeaning":{"publicId":"6005570","version":"1","preferredName":"Breast Cancer pT1a TNM Finding v8","longName":"6005570","preferredDefinition":"Breast cancer with tumor size more than 1 mm, but not more than 5 mm in greatest dimension (round any measurement 1.0-1.9 mm to 2 mm). (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT1a TNM Finding v8","conceptCode":"C139418","definition":"Breast cancer with tumor size more than 1 mm, but not more than 5 mm in greatest dimension (round any measurement 1.0-1.9 mm to 2 mm). (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE6D641-88B9-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE7D752-94A2-1195-E053-F662850ACE00","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"TX","valueDescription":"Breast Cancer pTX TNM Finding v8","ValueMeaning":{"publicId":"6005593","version":"1","preferredName":"Breast Cancer pTX TNM Finding v8","longName":"6005593","preferredDefinition":"Breast cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTX TNM Finding v8","conceptCode":"C139412","definition":"Breast cancer in which the primary tumor cannot be assessed. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE74FD3-9999-0511-E053-F662850A044F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE74FD3-99B2-0511-E053-F662850A044F","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T4d","valueDescription":"Breast Cancer pT4d TNM Finding v8","ValueMeaning":{"publicId":"6005597","version":"1","preferredName":"Breast Cancer pT4d TNM Finding v8","longName":"6005597","preferredDefinition":"Breast cancer meeting the criteria of inflammatory carcinoma. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT4d TNM Finding v8","conceptCode":"C139427","definition":"Breast cancer meeting the criteria of inflammatory carcinoma. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE74FD3-99E5-0511-E053-F662850A044F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE74FD3-99FE-0511-E053-F662850A044F","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T4c","valueDescription":"Breast Cancer pT4c TNM Finding v8","ValueMeaning":{"publicId":"6005588","version":"1","preferredName":"Breast Cancer pT4c TNM Finding v8","longName":"6005588","preferredDefinition":"Breast cancer in which both T4a and T4b are present. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT4c TNM Finding v8","conceptCode":"C139426","definition":"Breast cancer in which both T4a and T4b are present. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE72A02-9250-583F-E053-F662850A0711","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE74FD3-9A12-0511-E053-F662850A044F","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"Tis (DCIS)","valueDescription":"Breast Cancer pTis (DCIS) TNM Finding v8","ValueMeaning":{"publicId":"6005599","version":"1","preferredName":"Breast Cancer pTis (DCIS) TNM Finding v8","longName":"6005599","preferredDefinition":"Breast cancer with a finding of ductal carcinoma in situ. Lobular carcinoma in situ (LCIS) is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis (DCIS) TNM Finding v8","conceptCode":"C139414","definition":"Breast cancer with a finding of ductal carcinoma in situ. Lobular carcinoma in situ (LCIS) is a benign entity and is removed from TNM staging in the AJCC Cancer Staging Manual, 8th Edition. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE74FD3-9A1F-0511-E053-F662850A044F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE74FD3-9A38-0511-E053-F662850A044F","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T1c","valueDescription":"Breast Cancer pT1c TNM Finding v8","ValueMeaning":{"publicId":"6005566","version":"1","preferredName":"Breast Cancer pT1c TNM Finding v8","longName":"6005566","preferredDefinition":"Breast cancer with tumor size more than 10 mm, but not more than 20 mm in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT1c TNM Finding v8","conceptCode":"C139420","definition":"Breast cancer with tumor size more than 10 mm, but not more than 20 mm in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE6D641-886D-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE6D641-8886-6605-E053-F662850A8C04","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T1b","valueDescription":"Breast Cancer pT1b TNM Finding v8","ValueMeaning":{"publicId":"6005568","version":"1","preferredName":"Breast Cancer pT1b TNM Finding v8","longName":"6005568","preferredDefinition":"Breast cancer with tumor size more than 5 mm, but not more than 10 mm in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT1b TNM Finding v8","conceptCode":"C139419","definition":"Breast cancer with tumor size more than 5 mm, but not more than 10 mm in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE6D641-8893-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE6D641-88AC-6605-E053-F662850A8C04","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T1","valueDescription":"Breast Cancer pT1 TNM Finding v8","ValueMeaning":{"publicId":"6005572","version":"1","preferredName":"Breast Cancer pT1 TNM Finding v8","longName":"6005572","preferredDefinition":"Breast cancer with tumor size 20 mm or less in greatest dimension. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT1 TNM Finding v8","conceptCode":"C139416","definition":"Breast cancer with tumor size 20 mm or less in greatest dimension. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE6D641-88DF-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE6D641-88F8-6605-E053-F662850A8C04","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"T0","valueDescription":"Breast Cancer pT0 TNM Finding v8","ValueMeaning":{"publicId":"6005574","version":"1","preferredName":"Breast Cancer pT0 TNM Finding v8","longName":"6005574","preferredDefinition":"Breast cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pT0 TNM Finding v8","conceptCode":"C139413","definition":"Breast cancer with no evidence of primary tumor. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE6D641-8905-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"5BE6D641-891E-6605-E053-F662850A8C04","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"ONEDATA","dateModified":"2017-10-19","deletedIndicator":"No"},{"value":"Tis (Paget)","valueDescription":"Breast Cancer pTis (Paget) TNM Finding v8","ValueMeaning":{"publicId":"6005595","version":"1","preferredName":"Breast Cancer pTis (Paget) TNM Finding v8","longName":"6005595","preferredDefinition":"Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS) in the underlying breast parenchyma. Carcinomas in the breast parenchyma associated with Paget disease are categorized based on the size and characteristics of the parenchymal disease, although the presence of Paget disease should still be noted. (from AJCC 8th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer pTis (Paget) TNM Finding v8","conceptCode":"C139415","definition":"Paget disease of the nipple not associated with invasive carcinoma and/or carcinoma in situ (DCIS) in the underlying breast parenchyma. Carcinomas in the breast parenchyma associated with Paget disease are categorized based on the size and characteristics of the parenchymal disease, although the presence of Paget disease should still be noted. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5BE74FD3-99BF-0511-E053-F662850A044F","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"87EE20EB-7674-3D52-E053-F662850A5489","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-05-02","modifiedBy":"ONEDATA","dateModified":"2019-05-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"6356795","version":"1","preferredName":"Breast Cancer TNM Finding v8 American Joint Committee on Cancer T Category Category","preferredDefinition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.):A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).:A grouping of items based on some commonality or by user defined characteristics.","longName":"C139390:C39315:C25728:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer TNM Finding v8","conceptCode":"C139390","definition":"A finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v8 classification system. This classification system applies to invasive (infiltrating) carcinoma of the breast and ductal carcinoma in situ of the breast. It does not apply to breast sarcoma, phyllodes tumor, and breast lymphoma. (from AJCC 8th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"T Category","conceptCode":"C25728","definition":"One criteria of the TNM staging system. T refers to the extent of tumor involvement at the primary site (T, followed by a number indicating size and depth of invasion).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71354952-E136-04E4-E053-F662850A9FF1","latestVersionIndicator":"Yes","beginDate":"2018-07-17","endDate":null,"createdBy":"TAYLORT","dateCreated":"2018-07-17","modifiedBy":"ONEDATA","dateModified":"2018-07-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5BE6D641-8851-6605-E053-F662850A8C04","latestVersionIndicator":"Yes","beginDate":"2017-10-19","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-19","modifiedBy":"TAYLORT","dateModified":"2019-05-03","changeDescription":"5-3-19 released; tmt. 7/17/18 tt updated/Focus Group recommendations. 11/17/17 tt associated with CS/CSI. 10/19/17 tt Created for standard harmonization; supercedes VD 3419225.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643181","version":"1","longName":"Initial Diagnosis","context":"MCL"},{"publicId":"7035094","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000338","version":"1","longName":"Breast","context":"NCI Standards"},{"publicId":"6005920","version":"1","longName":"AJCC Edition 8","context":"NCI Standards"}]},{"publicId":"6437797","version":"1","longName":"Pre-Cancer Atlas Pilot","context":"MCL","ClassificationSchemeItems":[{"publicId":"7001791","version":"1","longName":"Breast PCA Pilot","context":"MCL"}]}],"AlternateNames":[{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"path_TNM_class_T_8","type":"MCL Alt Name","context":"MCL"}],"ReferenceDocuments":[{"name":"Pathologic T category","type":"Preferred Question Text","description":"Pathologic T category","url":null,"context":"NCI Standards"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"breast_v1-2_08sep2020.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"5AB9D86F-C190-20CF-E053-F662850A491C","latestVersionIndicator":"Yes","beginDate":"2017-10-04","endDate":null,"createdBy":"TAYLORT","dateCreated":"2017-10-04","modifiedBy":"COLBERTM","dateModified":"2021-11-22","changeDescription":"11/22/21 mr Added MCL PCA breast CSI, alt name, alt def, ref doc per DCT.   5-3-19 released; tmt. 7/17/18 tt updated/Focus Group recommendations.  12/6/17 tt associated with VD.  11/17/17 tt associated with CS/CSI. 10/4/17 tt created for standardization. Incomplete pending updates to VD per NCIt Ed 8 caDSR concept loading; supercedes CDE 3419393.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}